ID23554A - Formulasi-formulasi intranasal untuk pengobatan penyakit-penyakit seksual - Google Patents

Formulasi-formulasi intranasal untuk pengobatan penyakit-penyakit seksual

Info

Publication number
ID23554A
ID23554A IDP990592D ID990592D ID23554A ID 23554 A ID23554 A ID 23554A ID P990592 D IDP990592 D ID P990592D ID 990592 D ID990592 D ID 990592D ID 23554 A ID23554 A ID 23554A
Authority
ID
Indonesia
Prior art keywords
treatment
intranasal formulations
sexual diseases
sexual
diseases
Prior art date
Application number
IDP990592D
Other languages
English (en)
Indonesian (id)
Inventor
Anne Billotte
Peter James Dunn
Brian Thomas Henry
Peter Vallance Marshall
Joanna Jayne Eoods
Original Assignee
Pfizer Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9813452.1A external-priority patent/GB9813452D0/en
Priority claimed from GBGB9820837.4A external-priority patent/GB9820837D0/en
Priority claimed from GBGB9903177.5A external-priority patent/GB9903177D0/en
Application filed by Pfizer Res & Dev filed Critical Pfizer Res & Dev
Publication of ID23554A publication Critical patent/ID23554A/id

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Otolaryngology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IDP990592D 1998-06-22 1999-06-21 Formulasi-formulasi intranasal untuk pengobatan penyakit-penyakit seksual ID23554A (id)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GBGB9813452.1A GB9813452D0 (en) 1998-06-22 1998-06-22 Pharmaceutical formulations
GBGB9820837.4A GB9820837D0 (en) 1998-09-24 1998-09-24 Pharmaceutical formulations
GBGB9903177.5A GB9903177D0 (en) 1999-02-13 1999-02-13 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
ID23554A true ID23554A (id) 2000-05-04

Family

ID=27269368

Family Applications (1)

Application Number Title Priority Date Filing Date
IDP990592D ID23554A (id) 1998-06-22 1999-06-21 Formulasi-formulasi intranasal untuk pengobatan penyakit-penyakit seksual

Country Status (40)

Country Link
US (2) US20020040139A1 (de)
EP (1) EP0967214B1 (de)
JP (1) JP3263379B2 (de)
KR (1) KR100345824B1 (de)
AP (1) AP1178A (de)
AR (1) AR016993A1 (de)
AT (1) ATE269866T1 (de)
AU (1) AU746865B2 (de)
BG (1) BG64372B1 (de)
BR (1) BR9903273A (de)
CA (1) CA2275554C (de)
CZ (1) CZ294856B6 (de)
DE (1) DE69918222T2 (de)
DK (1) DK0967214T3 (de)
DZ (1) DZ2826A1 (de)
EA (1) EA001903B1 (de)
ES (1) ES2221733T3 (de)
GT (1) GT199900095A (de)
HN (1) HN1999000096A (de)
HR (1) HRP990195B1 (de)
HU (1) HUP9902076A3 (de)
ID (1) ID23554A (de)
IL (1) IL130539A0 (de)
IS (1) IS5085A (de)
MA (1) MA25089A1 (de)
MY (1) MY117967A (de)
NO (1) NO317365B1 (de)
NZ (1) NZ336382A (de)
OA (1) OA11069A (de)
PA (1) PA8476301A1 (de)
PE (1) PE20000702A1 (de)
PT (1) PT967214E (de)
SG (1) SG77246A1 (de)
SI (1) SI0967214T1 (de)
SK (1) SK284574B6 (de)
TN (1) TNSN99129A1 (de)
TR (1) TR199901444A2 (de)
TW (1) TWI223598B (de)
UA (1) UA59385C2 (de)
YU (1) YU29699A (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6200591B1 (en) 1998-06-25 2001-03-13 Anwar A. Hussain Method of administration of sildenafil to produce instantaneous response for the treatment of erectile dysfunction
GB9828340D0 (en) * 1998-12-22 1999-02-17 Novartis Ag Organic compounds
WO2001035926A2 (en) * 1999-11-18 2001-05-25 Natco Pharma Limited An improved pharmaceutical composition for treating male erectile dysfunction
KR20010016165A (ko) * 2000-11-16 2001-03-05 정순학 성기능 장애 치료를 위한 피부에 적용하는 제제
DE10118306A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Imidazotriazinonhaltige Zusammensetzungen zur nasalen Applikation
DE10118305A1 (de) * 2001-04-12 2002-10-17 Bayer Ag Zusammensetzungen zur nasalen Applikation
US7458374B2 (en) 2002-05-13 2008-12-02 Alexza Pharmaceuticals, Inc. Method and apparatus for vaporizing a compound
US20070122353A1 (en) 2001-05-24 2007-05-31 Hale Ron L Drug condensation aerosols and kits
AU2002310086B2 (en) * 2001-05-24 2008-09-04 Alexza Pharmaceuticals, Inc. Delivery of erectile dysfunction drugs through an inhalation route
US20030051728A1 (en) 2001-06-05 2003-03-20 Lloyd Peter M. Method and device for delivering a physiologically active compound
US7090830B2 (en) 2001-05-24 2006-08-15 Alexza Pharmaceuticals, Inc. Drug condensation aerosols and kits
US7585493B2 (en) 2001-05-24 2009-09-08 Alexza Pharmaceuticals, Inc. Thin-film drug delivery article and method of use
US7645442B2 (en) 2001-05-24 2010-01-12 Alexza Pharmaceuticals, Inc. Rapid-heating drug delivery article and method of use
CA2446904A1 (en) 2001-05-24 2003-04-03 Alexza Pharmaceuticals, Inc. Delivery of drug esters through an inhalation route
DE10248601B4 (de) * 2002-10-17 2006-05-24 Goldstein, Naum, Dr.habil.nat. Pharmazeutisches Mittel zur endonasalen Applikation bei der Behandlung von Krankheiten und Störungen des zentralen Nervensystems
US20040105818A1 (en) 2002-11-26 2004-06-03 Alexza Molecular Delivery Corporation Diuretic aerosols and methods of making and using them
US7913688B2 (en) 2002-11-27 2011-03-29 Alexza Pharmaceuticals, Inc. Inhalation device for producing a drug aerosol
US7138107B2 (en) * 2003-02-18 2006-11-21 Compellis Pharmaceuticals Inhibition of olfactory neurosensory function to treat eating disorders and obesity
WO2004073729A1 (ja) 2003-02-21 2004-09-02 Translational Research Ltd. 薬物の経鼻投与用組成物
US7278982B2 (en) 2003-03-27 2007-10-09 Bioactis Limited Powder medicine applicator for nasal cavity
AR043880A1 (es) * 2003-04-22 2005-08-17 Solvay Pharm Gmbh Mesilato acido de 4-(4.trans-hidroxiciclohexil) amino-2-fenil-7h-pirrolo (2,3-d) pirimidina y sus formas polimorfas
WO2004104492A2 (en) 2003-05-21 2004-12-02 Alexza Pharmaceuticals, Inc. Optically ignited or electrically ignited self-contained heating unit and drug-supply unit employing same
US7540286B2 (en) 2004-06-03 2009-06-02 Alexza Pharmaceuticals, Inc. Multiple dose condensation aerosol devices and methods of forming condensation aerosols
EP1785145A4 (de) * 2004-08-10 2008-08-13 Translational Res Ltd Transnasale zusammensetzung mit sofortiger wirkung und hoher resorbierbarkeit
AU2004322756B2 (en) 2004-08-12 2011-04-14 Alexza Pharmaceuticals, Inc. Aerosol drug delivery device incorporating percussively activated heat packages
US9895444B2 (en) 2004-08-25 2018-02-20 Aegis Therapeutics, Llc Compositions for drug administration
US8268791B2 (en) * 2004-08-25 2012-09-18 Aegis Therapeutics, Llc. Alkylglycoside compositions for drug administration
US20140162965A1 (en) 2004-08-25 2014-06-12 Aegis Therapeutics, Inc. Compositions for oral drug administration
US20060046962A1 (en) 2004-08-25 2006-03-02 Aegis Therapeutics Llc Absorption enhancers for drug administration
US20090047347A1 (en) * 2005-07-29 2009-02-19 Aegis Therapeutics, Inc. Compositions for Drug Administration
NZ554183A (en) 2004-10-18 2009-04-30 Polymun Scient Immunbio Forsch Liposomal composition comprising an active ingredient for relaxing smooth muscle production and therapeutically use of said composition
EP1858554A2 (de) * 2005-03-09 2007-11-28 Boehringer Ingelheim International GmbH Neue pharmazeutische zusammensetzungen auf basis von anticholinergika und pde-5-hemmern
US8648100B2 (en) 2005-04-19 2014-02-11 Takeda Gmbh Roflumilast for the treatment of pulmonary hypertension
US8506934B2 (en) 2005-04-29 2013-08-13 Robert I. Henkin Methods for detection of biological substances
US20070098804A1 (en) * 2005-08-29 2007-05-03 Judith Aronhime Solid particulate tadalafil having a bimodal particle size distribution
GB0526283D0 (en) * 2005-12-23 2006-02-01 Givaudan Sa Compositions
GB0606234D0 (en) * 2006-03-29 2006-05-10 Pliva Istrazivanje I Razvoj D Pharmaceutically acceptable salts and polymorphic forms
US8226949B2 (en) 2006-06-23 2012-07-24 Aegis Therapeutics Llc Stabilizing alkylglycoside compositions and methods thereof
CN101668544B (zh) * 2006-12-26 2013-04-24 株式会社新日本科学 经鼻投用制剂
WO2008095136A2 (en) 2007-01-31 2008-08-07 Henkin Robert I Methods for detection of biological substances
ES2594867T3 (es) 2007-03-09 2016-12-23 Alexza Pharmaceuticals, Inc. Unidad de calentamiento para usar en un dispositivo de administración de fármaco
DE102008004893A1 (de) * 2008-01-17 2009-07-23 Add Technologies Ltd. Trägerpellets, Verfahren zu deren Herstellung und deren Verwendung
US20110033506A1 (en) * 2008-02-08 2011-02-10 Adel Penhasi Combination dosage form of low-dose modafinil and low-dose sildenafil
CA2756690C (en) 2008-03-28 2016-08-16 Hale Biopharma Ventures, Llc Administration of benzodiazepine compositions
CN102056568B (zh) 2008-06-04 2013-08-21 高露洁-棕榄公司 具有气穴系统的口腔护理器具
US20100104624A1 (en) * 2008-06-11 2010-04-29 Peter Langecker Combination therapy using phosphodiesterase inhibitors
US8580801B2 (en) 2008-07-23 2013-11-12 Robert I. Henkin Phosphodiesterase inhibitor treatment
US8440631B2 (en) 2008-12-22 2013-05-14 Aegis Therapeutics, Llc Compositions for drug administration
EP2429495A4 (de) * 2009-05-15 2014-01-22 Shin Nippon Biomedical Lab Ltd Intranasale pharmazeutische zusammensetzung mit verbesserter pharmakokinetik
JP2011001317A (ja) * 2009-06-19 2011-01-06 Fumakilla Ltd 鼻用洗浄剤
US8827946B2 (en) * 2009-07-31 2014-09-09 Shin Nippon Biomedical Laboratories, Ltd. Intranasal granisetron and nasal applicator
AU2011252040C1 (en) 2010-05-10 2015-04-02 Euro-Celtique S.A. Manufacturing of active-free granules and tablets comprising the same
NZ603170A (en) 2010-05-10 2015-04-24 Euro Celtique Sa Combination of active loaded granules with additional actives
EP4085899A1 (de) 2011-06-14 2022-11-09 Neurelis, Inc. Verabreichung von benzodiazepin
CN102952138B (zh) * 2011-08-17 2016-07-06 上海特化医药科技有限公司 一种吡唑并嘧啶酮化合物的盐、多晶型物及其药物组合物、制备方法和应用
GB2497933B (en) * 2011-12-21 2014-12-24 Londonpharma Ltd Drug delivery technology
US20150297601A1 (en) * 2012-10-05 2015-10-22 Robert I. Henkin Phosphodiesterase inhibitor treatment
CA2881144A1 (en) * 2012-11-09 2014-05-09 Purdue Pharma Pharmaceutical compositions comprising hydromorphone and naloxone
RU2536425C2 (ru) * 2013-01-17 2014-12-20 Общество с ограниченной ответственностью "Фармамед" Фармацевтическая композиция, содержащая силденафил цитрат, и способ ее приготовления
WO2014143453A1 (en) * 2013-03-15 2014-09-18 Henkin Robert I Phosphodiesterase inhibitor treatment
WO2015071380A1 (en) 2013-11-13 2015-05-21 Euro-Celtique S.A. Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
WO2015126944A1 (en) 2014-02-18 2015-08-27 Henkin Robert I Methods and compositions for diagnosing and treating loss and/or distortion of taste or smell
NO2723977T3 (de) 2014-03-19 2018-03-10
CA2994709A1 (en) * 2015-08-03 2017-02-09 Synergistic Therapeutics, Llc Sexual dysfunction therapeutic gel
US11458201B2 (en) 2016-10-31 2022-10-04 Suda Ltd. Mucosal active agent delivery
ES2880474T3 (es) * 2017-03-02 2021-11-24 Dutch Renewable Energy B V Administración intranasal de sustancias fisiológicamente activas
US11744967B2 (en) 2017-09-26 2023-09-05 Shin Nippon Biomedical Laboratories, Ltd. Intranasal delivery devices
AU2018397436A1 (en) 2017-12-26 2020-08-13 Ftf Pharma Private Limited Liquid oral formulations for PDE V inhibitors
US12214118B2 (en) 2018-02-02 2025-02-04 Alexza Pharmaceuticals, Inc. Electrical condensation aerosol device
WO2019157099A1 (en) 2018-02-06 2019-08-15 Aegis Therapeutics, Llc Intranasal epinephrine formulations and methods for the treatment of disease
EP3781191A4 (de) * 2018-04-16 2022-01-19 Barista Mist Pty Ltd Koffeinzusammensetzungen und verfahren zur verwendung
SE542968C2 (en) * 2018-10-26 2020-09-22 Lindahl Anders Treatment of osteoarthritis
US12569493B2 (en) 2020-03-24 2026-03-10 Cyrano Therapeutics Inc. Treatment of chemosensory dysfunction from a coronavirus infection
US20220111162A1 (en) * 2020-07-29 2022-04-14 Lido Ventures Llc Apparatus, system, and method for facilitating intranasal treatment of a patient

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5250534A (en) * 1990-06-20 1993-10-05 Pfizer Inc. Pyrazolopyrimidinone antianginal agents
GB9311920D0 (en) * 1993-06-09 1993-07-28 Pfizer Ltd Therapeutic agents
US5565466A (en) * 1993-08-13 1996-10-15 Zonagen, Inc. Methods for modulating the human sexual response
ES2122764T3 (es) * 1995-11-20 1998-12-16 Lilly Co Eli Inhibidor de la proteina quinasa c.
AU739417B2 (en) * 1997-05-29 2001-10-11 Mochida Pharmaceutical Co., Ltd. Therapeutic agent for erection dysfunction
ES2249846T3 (es) * 1997-12-02 2006-04-01 Archimedes Development Limited Composiciones para administracion nasal.
US6087368A (en) * 1998-06-08 2000-07-11 Bristol-Myers Squibb Company Quinazolinone inhibitors of cGMP phosphodiesterase

Also Published As

Publication number Publication date
IL130539A0 (en) 2000-06-01
YU29699A (sh) 2003-02-28
OA11069A (en) 2002-03-13
NZ336382A (en) 1999-11-29
DE69918222T2 (de) 2005-07-28
MA25089A1 (fr) 2000-12-31
KR20000006310A (ko) 2000-01-25
PT967214E (pt) 2004-08-31
HRP990195B1 (en) 2003-04-30
BG103510A (en) 2000-01-31
SK284574B6 (sk) 2005-06-02
HRP990195A2 (en) 2000-02-29
EA199900487A3 (ru) 2000-04-24
DE69918222D1 (de) 2004-07-29
KR100345824B1 (ko) 2002-07-24
AP9901585A0 (en) 1999-06-30
BG64372B1 (bg) 2004-12-30
NO993051L (no) 1999-12-23
ES2221733T3 (es) 2005-01-01
PA8476301A1 (es) 2000-09-29
MY117967A (en) 2004-08-30
TNSN99129A1 (fr) 2005-11-10
US20020040139A1 (en) 2002-04-04
AR016993A1 (es) 2001-08-01
AU3579499A (en) 2000-01-06
HUP9902076A3 (en) 2002-03-28
US20030158206A1 (en) 2003-08-21
SG77246A1 (en) 2000-12-19
AP1178A (en) 2003-06-30
HUP9902076A2 (hu) 2000-05-28
HU9902076D0 (en) 1999-08-30
TR199901444A2 (xx) 2000-01-21
AU746865B2 (en) 2002-05-02
GT199900095A (es) 2000-12-13
NO317365B1 (no) 2004-10-18
JP3263379B2 (ja) 2002-03-04
SK81999A3 (en) 2001-01-18
EA001903B1 (ru) 2001-10-22
CA2275554C (en) 2003-06-03
UA59385C2 (uk) 2003-09-15
CZ9902257A3 (cs) 2000-11-15
DK0967214T3 (da) 2004-09-27
EP0967214A1 (de) 1999-12-29
PE20000702A1 (es) 2000-08-16
JP2000034232A (ja) 2000-02-02
CZ294856B6 (cs) 2005-03-16
EP0967214B1 (de) 2004-06-23
IS5085A (is) 1999-12-23
EA199900487A2 (ru) 1999-12-29
DZ2826A1 (fr) 2003-12-01
ATE269866T1 (de) 2004-07-15
TWI223598B (en) 2004-11-11
HN1999000096A (es) 2000-12-03
CA2275554A1 (en) 1999-12-22
BR9903273A (pt) 2000-05-09
SI0967214T1 (en) 2004-10-31
NO993051D0 (no) 1999-06-21

Similar Documents

Publication Publication Date Title
ID23554A (id) Formulasi-formulasi intranasal untuk pengobatan penyakit-penyakit seksual
ATE262331T1 (de) Heterocyclische vinylether zur behandlung neurologischer krankheiten
ID25921A (id) Sulfonamida-sulfonamida untuk pengobatan penyakit-penyakit yang dimediakan endotelin
FIU20060389U0 (fi) Luusairauksien hoito
ID30062A (id) Alanog-analog benzopiran tersubstitusi untuk pengobatan radang
ID25792A (id) Antibodi-antibodi terhadap cd40 manusia
PL362711A1 (en) Morpholin-acetamide derivatives for the treatment of inflammatory diseases
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
IS2325B (is) Örgerðar samsetningar epleróns
NO20003845L (no) Behandling av kvinnelig seksuell dysfunksjon
DE60103770D1 (de) Botulinumtoxin zur behandlung endokriner erkrankungen
ID26861A (id) Terapi gabungan untuk pengobatan depresi refaktori
HUP0400024A3 (en) Combination for treatment of neoplastic diseases
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
IL141273A0 (en) Improved method for targeted topical treatment of disease
DE60236743D1 (de) Zur behandlung androgenabhängiger krankheiten
ID27214A (id) Triazolopiridina untuk pengobatan gangguan trombosis
EP1411985A4 (de) Behandlung von parasitischen erkrankungen
GB2360453B (en) Treatment of skin conditions
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen
ID24922A (id) Terapi kombinasi untuk pengobatan aids
DE60114448D1 (de) Imidazolonderivate zur behandlung viraler krankheiten
NO20006383D0 (no) Fremgangsmåte for behandling
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
NO20031080L (no) Fettsyreanaloger for behandling av proliferative sykdommer